Desjardins Global Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.92M Sell
19,094
-4,834
-20% -$480K 0.21% 119
2023
Q3
$2.08M Sell
23,928
-1,219
-5% -$110K 0.23% 94
2023
Q2
$2.38M Sell
25,147
-4,996
-17% -$422K 0.27% 77
2023
Q1
$2.27M Buy
30,143
+2,091
+7% +$158K 0.29% 68
2022
Q4
$2.16M Sell
28,052
-3,445
-11% -$262K 0.34% 53
2022
Q3
$2.1M Buy
31,497
+3,087
+11% +$196K 0.27% 75
2022
Q2
$1.48M Sell
28,410
-27,524
-49% -$1.56M 0.19% 118
2022
Q1
$3.17M Sell
55,934
-10,084
-15% -$540K 0.28% 79
2021
Q4
$3.4M Buy
+66,018
New +$3.24M 0.29% 85

Other funds holding CAH

Desjardins Global Asset Management's CAH Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Cardinal Health (CAH) stake by 20% in Q4 2023, selling an estimated $480K and leaving 19,094 shares worth $1.92M. The position accounts for 0.21% of the portfolio, ranked #119.

Desjardins Global Asset Management first reported a position in CAH in Q4 2021 and has held it in 9 quarters since. The position peaked at $3.4M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • Desjardins Global Asset Management held 19,094 shares of Cardinal Health worth $1.92M as of Q4 2023.
  • Desjardins Global Asset Management sold 4,834 Cardinal Health shares in Q4 2023, an estimated $480K.
  • Cardinal Health made up 0.21% of Desjardins Global Asset Management's portfolio in Q4 2023, its #119 holding.
  • Desjardins Global Asset Management first reported a position in Cardinal Health in Q4 2021 and has held it in 9 quarters since.
  • Desjardins Global Asset Management's Cardinal Health position peaked at $3.4M in Q4 2021.
  • 1,037 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.